These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10332870

  • 1. Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo.
    Hyder F, Petroff OA, Mattson RH, Rothman DL.
    Magn Reson Med; 1999 May; 41(5):889-96. PubMed ID: 10332870
    [Abstract] [Full Text] [Related]

  • 2. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA, Hyder F, Collins T, Mattson RH, Rothman DL.
    Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
    [Abstract] [Full Text] [Related]

  • 3. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
    Petroff OA, Behar KL, Mattson RH, Rothman DL.
    J Neurochem; 1996 Dec; 67(6):2399-404. PubMed ID: 8931472
    [Abstract] [Full Text] [Related]

  • 4. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
    Petroff OA, Rothman DL, Behar KL, Mattson RH.
    Neurology; 1996 May; 46(5):1459-63. PubMed ID: 8628502
    [Abstract] [Full Text] [Related]

  • 5. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
    Rothman DL, Petroff OA, Behar KL, Mattson RH.
    Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5662-6. PubMed ID: 8516315
    [Abstract] [Full Text] [Related]

  • 6. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG, Weber OM, Duc CO, Weber B, Meier D, Russ W, Boesiger P, Wieser HG.
    Epilepsia; 2001 Jan 15; 42(1):29-40. PubMed ID: 11207782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients.
    Petroff OA, Hyder F, Rothman DL, Mattson RH.
    Epilepsia; 2000 Jun 15; 41(6):675-80. PubMed ID: 10840398
    [Abstract] [Full Text] [Related]

  • 12. GABA changes with vigabatrin in the developing human brain.
    Novotny EJ, Hyder F, Shevell M, Rothman DL.
    Epilepsia; 1999 Apr 15; 40(4):462-6. PubMed ID: 10219272
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy.
    Ke Y, Cohen BM, Bang JY, Yang M, Renshaw PF.
    Psychiatry Res; 2000 Dec 22; 100(3):169-78. PubMed ID: 11120443
    [Abstract] [Full Text] [Related]

  • 17. Brain GABA editing by localized in vivo (1)H magnetic resonance spectroscopy.
    Bielicki G, Chassain C, Renou JP, Farges MC, Vasson MP, Eschalier A, Durif F.
    NMR Biomed; 2004 Apr 22; 17(2):60-8. PubMed ID: 15052553
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
    Petroff OA, Rothman DL.
    Mol Neurobiol; 1998 Feb 22; 16(1):97-121. PubMed ID: 9554704
    [Abstract] [Full Text] [Related]

  • 20. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS.
    Verhoeff NP, Petroff OA, Hyder F, Zoghbi SS, Fujita M, Rajeevan N, Rothman DL, Seibyl JP, Mattson RH, Innis RB.
    Epilepsia; 1999 Oct 22; 40(10):1433-8. PubMed ID: 10528940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.